228 related articles for article (PubMed ID: 2738650)
1. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.
Wilbur DS; Hadley SW; Hylarides MD; Abrams PG; Beaumier PA; Morgan AC; Reno JM; Fritzberg AR
J Nucl Med; 1989 Feb; 30(2):216-26. PubMed ID: 2738650
[TBL] [Abstract][Full Text] [Related]
2. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
3. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
Smellie WJ; Dean CJ; Sacks NP; Zalutsky MR; Garg PK; Carnochan P; Eccles SA
Cancer Res; 1995 Dec; 55(23 Suppl):5842s-5846s. PubMed ID: 7493357
[TBL] [Abstract][Full Text] [Related]
5. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
Zalutsky MR; Noska MA; Colapinto EV; Garg PK; Bigner DD
Cancer Res; 1989 Oct; 49(20):5543-9. PubMed ID: 2477144
[TBL] [Abstract][Full Text] [Related]
7. Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using para-iodobenzoyl (PIB) conjugate.
Murray JL; Mujoo K; Wilmanns C; Mansfield P; Wilbur DS; Rosenblum MG
J Nucl Med; 1991 Feb; 32(2):279-87. PubMed ID: 1992032
[TBL] [Abstract][Full Text] [Related]
8. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
[TBL] [Abstract][Full Text] [Related]
10. Improved iodine radiolabels for monoclonal antibody therapy.
Stein R; Govindan SV; Mattes MJ; Chen S; Reed L; Newsome G; McBride BJ; Griffiths GL; Hansen HJ; Goldenberg DM
Cancer Res; 2003 Jan; 63(1):111-8. PubMed ID: 12517786
[TBL] [Abstract][Full Text] [Related]
11. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF
J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
[TBL] [Abstract][Full Text] [Related]
14. Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate.
Lindegren S; Frost S; Bäck T; Haglund E; Elgqvist J; Jensen H
J Nucl Med; 2008 Sep; 49(9):1537-45. PubMed ID: 18703591
[TBL] [Abstract][Full Text] [Related]
15. Potential of palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy.
Fawwaz RA; Wang TS; Srivastava SC; Rosen JM; Ferrone S; Hardy MA; Alderson PO
J Nucl Med; 1984 Jul; 25(7):796-9. PubMed ID: 6737078
[TBL] [Abstract][Full Text] [Related]
16. Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
Stein R; Govindan SV; Mattes MJ; Shih LB; Griffiths GL; Hansen HJ; Goldenberg DM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3079s-3087s. PubMed ID: 10541347
[TBL] [Abstract][Full Text] [Related]
17. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
Zalutsky MR; Narula AS
Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
[TBL] [Abstract][Full Text] [Related]
18. High efficiency iodination of monoclonal antibodies for radiotherapy.
Mather SJ; Ward BG
J Nucl Med; 1987 Jun; 28(6):1034-6. PubMed ID: 3585493
[TBL] [Abstract][Full Text] [Related]
19. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Reist CJ; Garg PK; Alston KL; Bigner DD; Zalutsky MR
Cancer Res; 1996 Nov; 56(21):4970-7. PubMed ID: 8895752
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of iodovinyl antibody conjugates: comparison with a p-iodobenzoyl conjugate and direct radioiodination.
Hadley SW; Wilbur DS
Bioconjug Chem; 1990; 1(2):154-61. PubMed ID: 2095212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
